These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 18167381)

  • 1. Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people.
    Cartsos VM; Zhu S; Zavras AI
    J Am Dent Assoc; 2008 Jan; 139(1):23-30. PubMed ID: 18167381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonates are associated with increased risk for jaw surgery in medical claims data: is it osteonecrosis?
    Zavras AI; Zhu S
    J Oral Maxillofac Surg; 2006 Jun; 64(6):917-23. PubMed ID: 16713806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteonecrosis of the jaw in older osteoporosis patients treated with intravenous bisphosphonates.
    Baillargeon J; Kuo YF; Lin YL; Wilkinson GS; Goodwin JS
    Ann Pharmacother; 2011 Oct; 45(10):1199-206. PubMed ID: 21954448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker.
    Pazianas M; Blumentals WA; Miller PD
    Osteoporos Int; 2008 Jun; 19(6):773-9. PubMed ID: 17999023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
    Dodson TB
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteonecrosis of the jaw after oral bisphosphonate for osteoporosis.
    Tong CK; Ho ST; Wong SL
    Hong Kong Med J; 2010 Apr; 16(2):145-8. PubMed ID: 20354251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.
    Skrepnek GH; Seal B; Tangirala M; Jeffcoat MK; Watts NB; Hay JW
    Gen Dent; 2010; 58(6):484-92; quiz 493-4. PubMed ID: 21062718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Bis-phossy jaws" - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw.
    Abu-Id MH; Warnke PH; Gottschalk J; Springer I; Wiltfang J; Acil Y; Russo PA; Kreusch T
    J Craniomaxillofac Surg; 2008 Mar; 36(2):95-103. PubMed ID: 18234504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates.
    Van Poznak C; Estilo C
    Oncology (Williston Park); 2006 Aug; 20(9):1053-62; discussion 1065-6. PubMed ID: 16986349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy.
    Wang EP; Kaban LB; Strewler GJ; Raje N; Troulis MJ
    J Oral Maxillofac Surg; 2007 Jul; 65(7):1328-31. PubMed ID: 17577497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bisphosphonates and osteonecrosis of the jaws].
    Urade M
    Clin Calcium; 2007 Feb; 17(2):241-8. PubMed ID: 17272882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.
    Lazarovici TS; Mesilaty-Gross S; Vered I; Pariente C; Kanety H; Givol N; Yahalom R; Taicher S; Yarom N
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2241-7. PubMed ID: 20728033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan.
    Urade M; Tanaka N; Furusawa K; Shimada J; Shibata T; Kirita T; Yamamoto T; Ikebe T; Kitagawa Y; Fukuta J
    J Oral Maxillofac Surg; 2011 Nov; 69(11):e364-71. PubMed ID: 21782307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
    Mavrokokki T; Cheng A; Stein B; Goss A
    J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bisphosphonates (BP) and osteonecrosis of the jaws; continuous treatment with Bisphosphonates should be considered].
    Mawatari T
    Clin Calcium; 2010 Nov; 20(11):1743-7. PubMed ID: 21066910
    [No Abstract]   [Full Text] [Related]  

  • 17. Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism.
    Otto S; Pautke C; Opelz C; Westphal I; Drosse I; Schwager J; Bauss F; Ehrenfeld M; Schieker M
    J Oral Maxillofac Surg; 2010 Nov; 68(11):2837-45. PubMed ID: 20971371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.
    Vahtsevanos K; Kyrgidis A; Verrou E; Katodritou E; Triaridis S; Andreadis CG; Boukovinas I; Koloutsos GE; Teleioudis Z; Kitikidou K; Paraskevopoulos P; Zervas K; Antoniades K
    J Clin Oncol; 2009 Nov; 27(32):5356-62. PubMed ID: 19805682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-specific risk for an osteonecrosis of the jaw under bisphosphonate therapy.
    Jung TI; Hoffmann F; Glaeske G; Felsenberg D
    J Cancer Res Clin Oncol; 2010 Mar; 136(3):363-70. PubMed ID: 19701651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.
    Ruggiero SL; Dodson TB; Assael LA; Landesberg R; Marx RE; Mehrotra B;
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):2-12. PubMed ID: 19371809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.